Biotechnology

Techseriesinsight > Blog > News > Biotechnology

May 25, 2026
PRNewswire
Biotechnology, News

CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies – Persistence Market Research

The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, with a CAGR...

May 22, 2026
PRNewswire
Biotechnology, News

Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Caris, the Caris Precision Oncology Alliance® (Caris POA) and collaborators from more than 60...

May 21, 2026
PRNewswire
Biotechnology, News

Volta Labs launches automated library preparation solution for the Oxford Nanopore Ligation Sequencing Kit V14

Volta Labs, maker of the Callisto™ Sample Prep System, today announced the availability of its DNA Library Preparation Application for the Oxford Nanopore Technologies Ligation Sequencing Kit V14 (SQK-LSK114)....

May 20, 2026
Business Wire
Biotechnology, News

Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026

Jupiter Endovascular, Inc. today announced that the SPIRARE II pivotal trial evaluating the use of the company’s Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE) met...

May 15, 2026
PRNewswire
Biotechnology, News

Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board

Atisama Therapeutics (formerly Rage Bio) (“Atisama” or the “Company”), an Australian clinical-stage biotechnology company developing novel splice-switching oligonucleotide (SSO) therapeutics for chronic inflammatory disease, today reported progress in the...

May 14, 2026
Business Wire
Biotechnology, News

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

A technology company leading the adoption of AI to advance precision medicine, today announced a new initiative with Bristol Myers Squibb (NYSE: BMY). This collaboration aims to leverage AI,...

SportsMed Physical Therapy Earns Best of 2026 Award

May 13, 2026
PRNewswire
Biotechnology, News

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

Azitra, Inc. (“Azitra” or the “Company”) (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the quarter...

May 7, 2026
Business Wire
Biotechnology, News

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

A medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a commercial agreement with Atelier Health, a premier concierge medical practice led by...

May 6, 2026
PRNewswire
Biotechnology, News

The Foundation Assar Gabrielsson Prize recipients 2026 awarded

Volvo Group – The Assar Gabrielsson Foundation has awarded Ketan Thombare as the winner in the basic science research category and Louise Carstam and Ella Äng Eklund as the...

April 22, 2026
Business Wire
Biotechnology, News

Prospera™ Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT

A global leader in cell-free DNA and precision medicine, today announced a broad body of evidence supporting its Prospera test at the 2026 International Society for Heart and Lung...